Thanks. Seen the Topol review before. Valid points but very emotionally involved. Clearly Atherogenics is just sloppy. But the CCF endpoint on the filtered dataset is clearly the 'industry standard'.
BTW - Topol later lost his title, probably due to this kind of emotional amplification. Smart smart guy - but a loose cannon who amplifies things due to being too emotionally involved.
Market Data 
Markets 
AI
